A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis

Non ancora tradotto Non ancora tradotto
Autori
Categoria Primary study
Registry of TrialsClinicalTrials.gov
Year 2011

This article is not included in any systematic review

This article is part of the following publication threads:
Loading references information
The study proposes to assess whether compared to placebo, CP-690,550 is effective, safe, and tolerable maintenance therapy in subjects with Ulcerative Colitis (UC). The study proposes to assess whether compared to placebo, CP-690,550 maintenance therapy more effectively achieves mucosal healing and improves quality of life in subjects with UC.The study proposes to assess CP-690,550 pharmacokinetic exposure during maintenance therapy in subjects over the age of 18 years with UC.
Epistemonikos ID: 15d395b6f69c3e7a2ac390a89466171e73b9f4ff
First added on: Mar 23, 2022